Dérivés de 1,3-dihydro-imidazo[4,5-c]quinolin-2-one comme inhibiteurs de kinase lipidique et/ou de kinase pi3

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

申请号：

EP10175369.7

公开号：

EP2292617B1

申请日:

2006.05.18

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

The invention relates to novel organic compounds of formula (I) processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof - alone or in combination with one or more other pharmaceutically active compounds - for the treatment of an inflammatory or obstructive airway disease, such as asthma, disorders commonly occurring in connection with transplantation, or a proliferative disease, such as a tumor disease.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/